Novel therapies for relapsed/refractory mantle cell lymphoma

标题

作者

关键词

Mantle cell lymphoma, Ibrutinib, Novel therapies, Bruton's tyrosine kinase inhibitors, Bortezomib, Lenalidomide, Relapsed, Refractory, Ibrutinib combinations

出版物

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Volume 31, Issue 1, Pages 105-113

出版商

Elsevier BV

发表日期

2017-11-21

DOI

10.1016/j.beha.2017.10.010

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started